The intracerebral hemorrhage (ICH) score is the most widely used and validated prognostic model for estimating 30‐day mortality in ICH. However, the score was developed and validated in an ICH population probably not using oral anticoagulants (OACs). The aim of this study was to determine the performance of the ICH score for predicting the 30‐day mortality rate in the full range of ICH scores in patients using OACs.

中文翻译：

---

脑出血评分使用口服抗凝剂预测脑出血患者预后的可靠性。

脑出血（ICH）评分是用于评估ICH的30天死亡率的最广泛使用和验证的预后模型。但是，该分数是在可能未使用口服抗凝剂（OAC）的ICH人群中开发和验证的。这项研究的目的是确定ICH评分的性能，以预测使用OAC的患者在整个ICH评分范围内的30天死亡率。